NAGE
Niagen Bioscience, Inc.
Nasdaq Medicinal Chemicals & Botanical Products Large accelerated filer

Key Financials

Operating Income
$16.3M
↑ 110.7%
Gross Profit
$83.2M
↑ 35.1%
Net Income
$17.4M
↑ 103.3%
Revenue
$129.4M
↑ 29.9%
EPS (Diluted)
$0.20
↑ 81.8%
Total Liabilities
$29.9M
↑ 34.7%
Shareholders' Equity
$76.5M
↑ 66.0%
Total Assets
$106.4M
↑ 55.8%

Recent SEC Filings

Form Type Filed Date Link
10-Q 8/4/2026 View on SEC
8-K 8/4/2026 View on SEC
SCHEDULE 13G 7/29/2026 View on SEC
424B5 7/10/2026 View on SEC
EFFECT 7/9/2026 View on SEC
4 7/8/2026 View on SEC
4 7/8/2026 View on SEC
4 7/8/2026 View on SEC
8-K 6/29/2026 View on SEC
S-3 6/29/2026 View on SEC

Company Information

Field Value
Ticker NAGE
Company Name Niagen Bioscience, Inc.
CIK 1386570
Sector Medicinal Chemicals & Botanical Products
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2833
SIC Description Medicinal Chemicals & Botanical Products
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 310-388-6706